Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 8,254 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: weight Clear all

Conditions: Atrial Fibrillation, Stroke, Bleeding
Interventions: Rivaroxaban, Warfarin; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-Alcoholic Fatty Liver Disease, Obesity
Interventions: Alternate day fasting, Exercise; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Respiration, Artificial, Critical Illness, Chronic Disease, Exercise Therapy, Rehabilitation, Physical Therapy Modalities
Interventions: multimodal physical therapy; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 20 Years to 100 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain
Interventions: SPRIX; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 12 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Multiple Myeloma
Interventions: Epoetin Alfa, Exercise, Autologous Peripheral Blood Stem Cell Transplantation, Red Blood Cell Transfusion, Thalidomide, Heparin, Low-Molecular-Weight, Platelet Transfusion, Melphalan, Total Therapy II; Drug · Behavioral · Biological
Lead sponsor: University of Arkansas; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Alzheimer's Disease, Healthy Volunteer
Interventions: [11C]RO6924963, [11C]RO6931643, [18F]RO6958948; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 25 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Recurrent Chronic Hepatitis C Virus, Post Liver Transplant
Interventions: Sofosbuvir, RBV; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 8
States / cities: San Francisco, California • Indianapolis, Indiana • Kansas City, Kansas + 4 more

Conditions: Type 2 Diabetes, Healthy, Impaired Glucose Tolerance
Interventions: Pioglitazone, Exenatide, Pioglitazone and Exenatide; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obesity, Schizophrenia, Schizoaffective Disorder
Interventions: Naltrexone 25mg, Placebo; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Morbid Obesity
Interventions: LAGB & LGCP; Procedure
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Syosset, New York

Conditions: Weight, Food Choice, Nutrition Intake
Interventions: Personalized nutrition feedback; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 75 Years
Enrollment: 602 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: omalizumab, Placebo; Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obesity
Interventions: Dietary Compliance; Behavioral
Lead sponsor: Rippe Lifestyle Institute; Industry
Eligibility: 20 Years to 60 Years
Enrollment: 366 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Celebration, Florida

Conditions: Spinal Cord Injuries
Interventions: NMES+FES, Control+FES; Device
Lead sponsor: United States Department of Defense; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 3
States / cities: The Bronx, New York • Richmond, Virginia

Conditions: Amputees, Running With Prosthesis
Interventions: Running on a treadmill at 6 different speeds; Other
Lead sponsor: Regis University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Weight Loss, Pain, Postoperative
Interventions: Topamax, Gabapentin; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 40 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 0
States / cities: Not listed

Conditions: Women's Health
Interventions: Resistance Training; Behavioral
Lead sponsor: Southern Illinois University Edwardsville; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Edwardsville, Illinois

Conditions: Infections, Bacterial
Interventions: GSK1322322 (mesylate salt) Powder for Injection, GSK1322322 (freebase) tablets, GSK1322322 (mesylate salt) Powder for Oral Solution, GSK1322322 (freebase) tablets FED; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obesity
Interventions: diet; Behavioral
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Liver Diseases, Liver Fibrosis, Liver Fat, Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis, MASLD, MASH, Weight Loss, Insulin Resistance, Insulin Sensitivity, Insulin Sensitivity/Resistance, Metabolic Disease, Diabetes, Diabetes Mellitus, Type 2, NASH With Fibrosis, Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Non-alcoholic Steatohepatitis
Interventions: ESG + lifestyle modification, Lifestyle modification; Device · Behavioral
Lead sponsor: Pichamol Jirapinyo, MD, MPH; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • Morgantown, West Virginia

Conditions: Melanoma (Skin), Non-melanomatous Skin Cancer
Interventions: educational intervention, internet-based intervention; Other
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 4,550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2004
U.S. locations: 5
States / cities: San Diego, California • Wichita, Kansas • Columbus, Ohio + 2 more

Conditions: Weight Gain
Interventions: Small Behavior Changes, Large Behavior Changes; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 599 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Providence, Rhode Island

Conditions: Type 2 Diabetes, Obesity
Interventions: Group Lifestyle Program, Usual Care; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fasting, Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Fasting, Diet, oral carbohydrate challenge; Behavioral · Dietary Supplement
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Alternate Day Fasting, Exercise, and NAFLD

Development of a Rehabilitation Strengthening and Mobility Program for Ventilator Dependent Older Patients

Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

Effects of Exercise in Combination With Epoetin Alfa

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Weight Loss & Comorbidity Resolution With LAGB Alone vs. LAGB With Gastric Plication

Promoting Employee Health Through The Worksite Food Environment

Effect of Anti-IgE in Non-Allergic Asthma

A Comparison of the Metabolic Effects of Fructose, Glucose, High Fructose Corn Syrup and Sucrose at Normal Population Consumed Levels in Adults Aged 20-60 Years Old

Skeletal Muscle Hypertrophy and Cardio-Metabolic Benefits After Spinal Cord Injury

Comparing Running-Specific and Traditional Prostheses During Running: Assessing Performance and Risk

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle

A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects

Effectiveness of Atkins Diet for Weight Loss

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control

Study of Novel Approaches for Prevention

Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study

Regulation of FGF21 by Nutritional Challenges